As part of its share buyback programme, dsm-firmenich has repurchased over 155,000 shares

dsm-firmenich, which operates in the nutrition, health and beauty sectors, announced that it had repurchased a total of 155,456 ordinary shares between 29 June and 3 July 2026 as part of its share buyback programme.

The company had announced its plan on 9 February 2026 to reduce its issued share capital by repurchasing ordinary shares with a total market value of 500 million euros. Subsequently, under the share buyback programme launched on 12 March 2026, share buybacks totalling 540 million euros were envisaged. Of this amount, 40 million euros was set aside to meet obligations arising from the group’s share-based remuneration schemes, whilst 500 million euros was earmarked for the reduction of issued share capital.

According to the company’s statement, 155,456 shares were repurchased at an average price of 82.45 euros during the period from 29 June to 3 July 2026. The total value of these transactions amounted to approximately 12.8 million euros.

Since the programme began, a total of 4,520,418 shares have been repurchased at an average price of 65.86 euros. Consequently, the total value of repurchases carried out to date has reached approximately 297.7 million euros.

The Group’s €40 million share buyback programme, aimed at its share-based remuneration schemes, is due to be completed on 23 March 2026, whilst the €500 million share buyback programme, aimed at reducing the issued share capital, is scheduled to be completed by the end of the third quarter of 2026.